1. Home
  2. ODV vs ALT Comparison

ODV vs ALT Comparison

Compare ODV & ALT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ODV
  • ALT
  • Stock Information
  • Founded
  • ODV 2005
  • ALT 1997
  • Country
  • ODV Canada
  • ALT United States
  • Employees
  • ODV N/A
  • ALT N/A
  • Industry
  • ODV Precious Metals
  • ALT Biotechnology: Pharmaceutical Preparations
  • Sector
  • ODV Basic Materials
  • ALT Health Care
  • Exchange
  • ODV Nasdaq
  • ALT Nasdaq
  • Market Cap
  • ODV 338.9M
  • ALT 292.0M
  • IPO Year
  • ODV N/A
  • ALT N/A
  • Fundamental
  • Price
  • ODV $2.72
  • ALT $3.83
  • Analyst Decision
  • ODV
  • ALT Strong Buy
  • Analyst Count
  • ODV 0
  • ALT 6
  • Target Price
  • ODV N/A
  • ALT $17.40
  • AVG Volume (30 Days)
  • ODV 1.1M
  • ALT 3.0M
  • Earning Date
  • ODV 08-12-2025
  • ALT 08-12-2025
  • Dividend Yield
  • ODV N/A
  • ALT N/A
  • EPS Growth
  • ODV N/A
  • ALT N/A
  • EPS
  • ODV N/A
  • ALT N/A
  • Revenue
  • ODV $5,147,156.00
  • ALT $20,000.00
  • Revenue This Year
  • ODV $381.12
  • ALT N/A
  • Revenue Next Year
  • ODV $256.81
  • ALT $761,880.20
  • P/E Ratio
  • ODV N/A
  • ALT N/A
  • Revenue Growth
  • ODV N/A
  • ALT N/A
  • 52 Week Low
  • ODV $1.16
  • ALT $2.90
  • 52 Week High
  • ODV $2.91
  • ALT $11.16
  • Technical
  • Relative Strength Index (RSI)
  • ODV 60.30
  • ALT 51.79
  • Support Level
  • ODV $2.43
  • ALT $3.35
  • Resistance Level
  • ODV $2.91
  • ALT $3.66
  • Average True Range (ATR)
  • ODV 0.14
  • ALT 0.19
  • MACD
  • ODV 0.02
  • ALT 0.07
  • Stochastic Oscillator
  • ODV 64.08
  • ALT 86.18

About ODV Osisko Development Corp.

Osisko Development Corp is a mineral exploration and development company engaged in the acquisition, exploration, and development of precious metals resource properties in North America. The company is focused on exploring and developing its mining assets, including the Cariboo Gold Project in British Columbia, the San Antonio gold project in Mexico, and the Trixie test mine in the USA. The Company manages its business through the exploration, evaluation, and development activities of its projects.

About ALT Altimmune Inc.

Altimmune Inc is a clinical-stage biopharmaceutical company focused on developing treatments for obesity, metabolic diseases, and liver diseases. Its product candidate, pemvidutide (formerly known as ALT-801), is a novel, investigational, peptide-based GLP-1/glucagon dual receptor agonist. Pemvidutide is currently in clinical development for obesity and metabolic-associated steatohepatitis (MASH). The company also plans to pursue additional indications for pemvidutide that leverage the differentiated clinical profile of pemvidutide.

Share on Social Networks: